ILD and PAH can occur in both diffuse and limited subsets but in general, the former develops more frequently in the diffuse subset with anti-topoisomerase I antibody (ATA) and the latter in the limited subset with anti-centromere antibody (ACA). Here, ATM is linked to pulmonary arterial hypertension.